ITI214 free base

• CAT Number: I000582
• CAS Number: 1160521-50-5
• Molecular Formula: C29H26FN7O
• Molecular Weight: 507.573
• Purity: ≥95%
• Target: Phosphodiesterase (PDE)
• Solubility: 10 mM in DMSO
• Storage: Store at -20°C
• IC50: 58 pM (Ki)
• InChI: InChI=1S/C29H26FN7O/c1-35-28(38)25-26(31-20-7-3-2-4-8-20)36(34-27(25)37-23-11-5-10-22(23)33-29(35)37)17-18-13-15-19(16-14-18)21-9-6-12-24(30)32-21/h2-4,6-9,12-16,22-23,31H,5,10-11,17H2,1H3/t22-,23+/m1/s1
• InChIKey: BBIPVJCGIASXJB-PKTZIBPZSA-N
• SMILES: CN1C(=O)C2=C(N(N=C2N3C1=NC4C3CCC4)CC5=CC=C(C=C5)C6=NC(=CC=C6)F)NC7=CC=CC=C7

ITI214 free base (Cat.No:I000582) is a small molecule compound that acts as a potent and selective inhibitor of phosphodiesterase 1 (PDE1). PDE1 inhibition has been shown to have potential therapeutic effects in various neurological and psychiatric disorders. ITI214 free base is being investigated for its potential in the treatment of cognitive impairment and mood disorders.

Reference

[1]. Li P, et al. Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases. J Med Chem. 2016 Feb 11;59(3):1149-64.
[2]. Lawrence Wennogle. Novel uses. From PCT Int. Appl. (2014), WO 2014145617 A2 20140918.
[3]. Peng Li , et al. Salt crystals. From PCT Int. Appl. (2013), WO 2013192556 A2 20131227.
[4]. Allen A. Fienberg, et al. Organic compounds. From PCT Int. Appl. (2010), WO 2010132127 A1 20101118.